Scott Braunstein's Net Worth
Estimate Recalculated May 19, 2025 08:11PM EST
Who is Scott Braunstein
Scott Braunstein does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ZIOPHARM ONCOLOGY INC, CONSTELLATION PHARMACEUTICALS INC, MARINUS PHARMACEUTICALS, INC., Caribou Biosciences, Inc., Esperion Therapeutics, Inc., Pacira Pharmaceuticals, Inc., TREVENA INC, ArTara Therapeutics, Inc., and ATAI Life Sciences N.V..
SEC CIK
Scott Braunstein's CIK is 0001643875
Past Insider Trading and Trends
2020 was Scott Braunstein's most active year for acquiring shares with 13 total transactions. Scott Braunstein's most active month to acquire stocks was the month of December. 2021 was Scott Braunstein's most active year for disposing of shares, totalling 3 transactions. Scott Braunstein's most active month to dispose stocks was the month of June. 2024 saw Scott Braunstein paying a total of $214,000.00 for 924,575 shares, this is the most they've acquired in one year. In 2024 Scott Braunstein cashed out on 73,995 shares for a total of $131,512.85, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
